LBF-funded research
The LBF is the only dedicated funder of haematology research and continues to sponsor two research groups, the Leukaemia Study Group and the Bone Marrow Transplant Study Group.
One of the cornerstones of our‘vision to cure’ has been the dedicated research grants we have provided for more than 30 years. To date, the LBF has funded $2 million in research into blood cancers and conditions.
In addition, we have funded summer research projects for students and travel grants for scientists, clinicians, nurses and laboratory staff to attend national and international scientific meetings.
The involvement of the LBF in research will ultimately lead to benefits and improved outcomes for New Zealand patients. There are also many indirect benefits, including the education of medical and nursing staff looking after patients with blood disorders, support of the haematology research environment, retention of scientist and clinicians in New Zealand, and the encouragement of young scientists and clinicians to consider a career in haematology and haematology research.
In addition, the LBF supports the Leukaemia Study Group and the Bone Marrow Transplant Study Group which provide valuable forums for haematologists around the country. The focus is primarily an update on opportunities to participate in clinical trials and at times cover other topics of importance to patients and treatment, such as access to medicines. Below are examples of some our funding.
2009
The LBF made a generous donation of $25,000 to Middlemore Tissue Bank recognising their mutual aims of advancing the treatment of blood cancers and related blood conditions. The donation will be used to purchase equipment for the new MTB facility.
Antithrombin project - summer studentship project, Wellington. The LBF funded the summer studentship project in 2007/8. The research team presented the data on antithrombin deficiency and pregnancy orally at the HAA meeting in Perth, Australia October 2008 and the data on antithrombin deficiency and surgery as a poster at the ISTH meeting in Boston, USA in 2009. The research team is hopeful that they will be able to submit the work as a paper.
2008
Dr Nuala Helsby & Professor Peter Browett: $34,612 - Is Cyclophosphamide Activation Compromised in Multiple Myeloma
Dr Suzanne Benjes & Associate Professor Christine Morris: $13,321 - BCF-ABL1 Recombination Mechanisms in Chronic Myeloid Leukaemia
2007
Associate Professor Christine Morris, So Young Moon & Dr Peter Ganly: $34,085.00 - FISH validation of novel genomic copy number variations associated with CLL identified by array of CGH
Associate Professor Christine Morris, Dr Sheryl Gough, Dr Tracy Hale & Dr Peter Ganly: $22,558.00 - Characterisation of genes newly implicated in acute lymphoblastic leukaemia
2006
Dr Peter Browett - $21,977.00: Inhibition of the phosphoinositide 3-kinase pathway in acute myeloid leukaemia
Dr Ian Morison & Dr Elizabeth Ledgerwood - $38,000.00: A study of New Zealand familial thrombocytopenia
2005
Dr Judith McKenzie - $25,050.00: Are naturally occurring soluble CD40 and CD83 functional?
Dr Paul Harper - $13,905.00: Protein Z dependent protease inhibitor (ZPI) mutations in thrombosis patients
2004
Dr Peter Browett - $6,056.74: The effect of imatinib mesylate (Gilvec TM) on bone metabolism in vitro and in vivo
Dr Sheryl Gough - $21,436.00: Novel Breakpoints & leukaemia genes, and their clinical prevalence
